Endocrine system diseases

NHS England to fund flash glucose monitoring devices for all eligible diabetes patients

All patients with diabetes who qualify for a flash glucose monitoring device will be able to receive it on prescription from April 2019, NHS England has announced.…

Lack of evidence to support statin use in non-cardiovascular conditions

There is a lack of ‘convincing’ evidence that statins improve outcomes in non-cardiovascular conditions, such as diabetes, a review has shown.…

Reducing suboptimal prescribing of glucagon-like peptide mimetics in type 2 diabetes

In 2016, spend on diabetes prescribing — and glucagon-like peptide 1 (GLP-1) mimetics, in particular — at NHS Hastings and Rother Clinical Commissioning Group (CCG) and NHS Eastbourne, Hailsham and Seaford CCG was significantly higher than expected, based on national prescribing pat…

Hospital medication errors affected 260,000 diabetes patients in 2017

Around 260,000 patients with diabetes experienced a medication error during a hospital stay in 2017, according to analysis published by the charity Diabetes UK.…

Continuing metformin when introducing sulfonylureas is safer than switching in T2DM, research shows

Switching to sulfonylureas increases the risk of serious adverse events compared with remaining on metformin in people with type 2 diabetes mellitus, according to research published in The BMJ.…

Insulin degludec significantly improves blood sugar control compared with insulin glargine, data show

Using electronic health record data, researchers found that HbA1c levels declined by 1.5% among insulin degludec-treated patients compared with 1.2% in those treated with insulin glargine U300 over six months.…

Glucose-lowering therapy does not slow progression in young people with type 2 diabetes

Treatment with glucose-lowering therapy does not maintain or improve pancreatic beta-cell function in young people recently diagnosed with impaired glucose tolerance or type 2 diabetes mellitus, a study has shown.…

Sex and BMI ‘could inform second-line diabetes treatment choice’

Sex and body mass index should be used to guide choice of second-line treatment for type 2 diabetes, a UK study has found.…

Identifying modifiable risk factors to reduce inpatient hypoglycaemia

Through analysing a randomly selected sample of patients with low blood glucose and diabetes over a course of a year, this prospective study found that a significant number of hypoglycaemia episodes were not treated to established protocol.…

Medication reviews cut prescribing in older people with diabetes

A review of older people with diabetes who take sulfonylureas led to 58% being deprescribed the medication, according to results of research carried out by the West Hampshire Clinical Commissioning Group.…